Announcements Trials
Browse Landscape

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Prostatic Neoplasms 37Carcinoma, Hepatocellular 3Stage II Prostate Adenocarcinoma 1Prostate-specific Membrane Antigen 1Ovarian Neoplasms 1Carcinoma, Lobular 1Carcinoma, Adenoid Cystic 1Biochemically Recurrent Prostate Carcinoma 1

Interventions

Paclitaxel 177Carboplatin 177Bevacizumab 72Topotecan 55liposomal doxorubicin 54Gemcitabine 53Cisplatin 46Docetaxel 39Cyclophosphamide 37olaparib 32Filgrastim 31pembrolizumab 29Doxorubicin 26niraparib 24Taxes 23Drug Therapy 23Peripheral Blood Stem Cell Transplantation 20Etoposide 17veliparib 15Nivolumab 14sargramostim 13Surveys and Questionnaires 13Immunoglobulin G 13Disulfides 13pazopanib 12Ifosfamide 12Albumin-Bound Paclitaxel 12durvalumab 11atezolizumab 11Trabectedin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Ovarian Neoplasms × gallium 68 PSMA-11 × Clear all
NCT03857087 2022-10-12

68Ga-PSMA PET in Diagnosing Metastasis in Patients With Ovarian Cancer

University of California, San Francisco

Completed
7 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡